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1 Background 
1.1 Temporomandibular disorders 
Temporomandibular disorders (TMD) comprise a category of chronic complaints of pain 
and/or mobility dysfunction of the orofacial region. The main symptoms are pain from 
the periauricular area of the temporomandibular joint (TMJ) and/or in the masticatory 
structures – sometimes radiating to the temples, head, and neck - clicking sounds from 
the temporomandibular joint, and restricted movement of the jaw (Dworkin & LeResche, 
1992). Psychological characteristics of TMD patients are mainly elevated levels of 
psychological distress, a relatively low correlation between physiological parameters and 
severity of pain and suffering, and interference with ability to perform activities of daily 
life due to pain or fatigue (Dworkin, 1995). Persistent orofacial pain is the main reason 
for seeking treatment for this disorder.   
In population samples, TMD occurs about twice as frequently in women as in 
men (LeResche, 1997). The range of prevalence of TMD in the adult population has been 
estimated as 3-15%, and TMD seems to occur most frequently in young adults, i.e., 20-50 
years of age (LeResche, 1997). The symptoms (complaints described by the patient) and 
clinical signs (functional changes detected by the clinician) of TMD seem to fluctuate 
considerably. For many patients, the symptoms and signs seem to decrease with age, with 
the exception of osteoarthrosis of the TMJ, which is more frequent in the elderly 
(Carlsson & LeResche, 1995). However, progression to significantly more severe pain or 
functional level of the masticatory system seems rare (Magnusson et al., 2005). Orofacial 
pain and clicking sounds of the TMJ are widespread in the general population, while only 
a minority develop symptoms grave enough to generate help-seeking behaviour (Rantala 
et al., 2004).
TMD is usually diagnosed according to the Research Diagnostic Criteria (RDC) 
described by Dworkin & LeResche (1992). Three main subgroups of TMD have been 
described based on their assumed orofacial structural origin. “Group I - Muscle 
disorders” is diagnosed if ongoing subjective pain and pain upon palpation is reported, 
with or without limitations of mouth opening. “Group II - Disc displacement” is 
diagnosed if the temporomandibular joint disc is displaced from its position between the 
condyle and the articular eminence, sometimes indicated by clicking sounds during jaw 
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movement, with or without subjective report of pain. “Group III - Arthralgia, arthritis, or 
arthrosis” is diagnosed if ongoing pain in the joint upon function or palpation is detected 
(arthralgia or arthritis), crepitations of the joint (arthritis or arthrosis) are present, or if 
morphological and/or structural deformities of the condyle and articular eminence are 
identified during imaging assessment (arthritis or arthrosis).  Among those diagnosed 
with TMD, muscle pain and disc displacement predominate (Dahlström, 1998).  Multiple 
TMD sub-diagnoses are common (LeResche, 1995), but the causal relationship between 
the sub-diagnoses is undecided. 
In addition to clinical examination of the orofacial region, the RDC classifies 
patients according to pain-related disability and psychological status in order to identify 
level of function and psychological distress, i.e., symptoms of anxiety, depression, and 
somatisation, of relevance for planning of and adherence to treatment regimes (Dworkin 
& LeResche, 1992). Although patients from Group I, relative to the other subgroups, 
have been found to exhibit higher levels of psychological distress in cross-sectional 
studies (Huang et al., 2002), it has been reported that the subgroups do not differ with 
respect to the clinical course of TMD over a 5-year period (Ohrbach & Dworkin, 1998) 
or with respect to multi-disciplinary treatment (Dworkin et al., 2002).     
The etiology of TMD is poorly understood (Sessle et al., 1995). As is the case 
with other chronic musculoskeletal pain disorders, TMD seems to be best explained from 
a biopsychosocial perspective (Gatchel & Turk, 1999). According to the theoretical work 
of Maixner and coworkers (Fillingim et al., 1996; Maixner et al., 1995), TMD is a 
psychophysiological disorder involving changes in endogenous regulatory pain pathways, 
resulting in maladaptive emotional, physiological and neuroendocrine responses to 
physical and psychological stressors. However, no specific models have been presented 
that aim to describe the relative contribution of and temporal relationship between the 
factors that may be involved in the etiology and pathogenesis of TMD. Hence, theoretical 
models of and research findings from studies of other chronic musculoskeletal pain 
conditions are frequently used to explain the development of TMD (e.g., Vierck, 2006).
Figure 1 describes a schematic model of factors that may be relevant for the 
development of TMD. The exposure or acute event is suggested to generate chronic TMD 
if one or several of the other factors listed inside the frame are present. Two-way arrows 
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indicate possible reciprocal associations. The present thesis discusses some of these 
variables, i.e., personality traits (Paper I), psychological distress (Paper I), general health 
complaints (Paper I), pain sensitivity (Paper II and IV), and physiological responding 
(Paper II-IV).
         Personality
Pain sensitivity TMD       General health complaints
                      
Psychological distress      Genetic factors and physiological responding
          
Exposure / injury / acute events 
Pain-free individual 
Figure 1. Suggested model of development of TMD in an originally pain-free individual. 
Adapted from the vulnerability-diathesis-stress model of chronic pain by Dworkin & 
Banks (1999).
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1.2 Nociception and pain
The International Association for the Study of Pain (IASP defines pain as “an unpleasant 
sensory and emotional experience associated with actual and potential tissue damage, or 
described in terms of such damage” (Merskey & Bogduk, 1994).  
 Nociception is the physiological activity in primary afferent neurons, in the spinal 
cord, and in supra-spinal structures. Stimulation of nociceptors (receptors responding to 
mechanical, thermal, or chemical agents that would result in tissue damage if persistent) 
triggers activation of the myelinated AG- and unmyelinated C-afferent axons. The 
afferent nerves terminate in the dorsal horn of the spinal chord, where they synapse with 
second-order neurons that are either nociceptive specific or wide dynamic range (WDR) 
neurons that respond to noxious and non-noxious events alike. Nociceptive stimuli from 
the orofacial region are carried mainly via the maxillary and mandibular branches of the 
trigeminal nerve (the 5th cranial nerve), and synapses with second-order neurons in the 
trigeminal subnucleus caudalis in the brainstem. The nociceptive signals ascend up the 
spinal chord (or the brainstem in the case of orofacial signals) primarily via the 
spinothalamic tract and mainly transmitted by glutamate, to the thalamus, and then 
project to the somatosensory cortex.  
Pain occurs when the individual interprets this activity as a signal of potential 
injury or illness, and thus adds an affective component to the sensory activities. While 
nociception is a sensory event, pain is a psychological experience. Nociception does not 
inevitably generate pain, and pain may occur in the absence of nociception.
Acute pain is strongly stimulus-dependent and occurs in response to activation of 
the nociceptors of the skin, muscles, viscera or other anatomical structures. Chronic pain 
is normally defined as persisting more than 6 months. Chronic pain may be referred to as 
a disorder of the central nervous system (CNS) structures involved in processing of 
nociceptive and pain signals. However, the peripheral and central processes involved in 
the chronification of pain are not well understood.  
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1.3 Personality traits and chronic pain
Psychological mechanisms, e.g., personality traits, may play a pivotal role in the 
development and maintenance of pain syndromes characterized by symptoms and 
functional impairment that are not readily explained by physiological findings (Barsky & 
Buros, 1999). Personality traits may be defined as ”…regularities or broad behavioral 
consistencies in the conduct of people. As such, traits represent basic categories of 
individual differences in functioning” (Pervin, 1996). The Five Factor Model (FFM) 
(Costa & McCrae, 1992) seems to be the most influential current theory of individual 
differences in personality (Hogan et al., 1997). Support for this model has been found in 
cross-cultural studies, longitudinal studies of personality development, studies of genetics 
and heritability, and studies of psychiatric populations (Pervin, 1996). The FFM describes 
personality along five broad dimensions of relatively stable behaviour patterns: 
Neuroticism (N), Extraversion (E), Openness to experience (O), Agreeableness or 
warmth (A), and Conscientiousness (C) (Costa & McCrae, 1992). 
Personality traits may be associated with illness and somatic symptoms in several 
ways. First, some personality traits may predispose individuals to somatic disease. The 
finding that interpersonal hostility has been found to predict future coronary heart disease 
through large and frequent activation of the autonomous nervous system is one example 
(Miller et al., 1996; Smith, 1992). However, in prospective studies, no personality traits 
have been identified as responsible for the development of chronic pain conditions in the 
sense that they predict physiological changes that generate chronic pain (Gatchel & 
Weisberg, 2000).
Second, personality traits may determine the perception and appraisal of pain and 
bodily sensations and whether these sensations are interpreted as a threat to health and 
physical function (Costa & McCrae, 1987; Ellington & Wiebe, 1999). Several studies 
have found a positive relationship between N and the presence of chronic pain
(BenDebba et al., 1997; Wade et al., 1992), however, this trait is largely unrelated to 
biological markers of illness (Costa & McCrae, 1992).
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Third, personality traits may determine health behaviour and thereby indirectly 
affect one’s health. Both A, C, and O have been found to be related to diet, exercise, and 
life-style choices (Booth-Kewley & Vickers, 1994; Ingledew & Bruning, 1999).
Fourth, coping with symptoms and illness and adherence to treatment regimes 
may be influenced by personality traits. Both N, E, and O seem to be related to coping 
with chronic pain (Nitch & Boone, 2004). There is a consensus on the importance of 
individual differences in emotional style, responses to illness, and choice of coping 
strategies for the outcome of treatment for TMD (e.g., Dworkin et al., 2002). Hence, a 
personality screening could provide valuable information for the design and 
implementation of treatment regimes.  
The studies summarised above represent valuable attempts at disentangling the 
personality – pain relationship at the cross-sectional level. However, most studies have 
concentrated on measuring only one or two personality traits. The term Negative 
Affectivity (NA; Watson, 1988) is often used interchangeably with N, and NA is not part 
of any larger theoretical framework explaining individual differences. This is unfortunate, 
as an exclusive focus on N or NA will not permit conclusions regarding the full coping 
resources of the individual (Marshall et al., 1994). The FFM aims to describe the 
comprehensive personality structure of the individual (Costa & McCrae, 1992), and will 
provide a broader picture of the individual’s psychological makeup.  
1.4 General health complaints in TMD patients 
TMD patients in general seem to exhibit a higher than average prevalence of anxiety and 
depression compared to healthy controls (Kight et al., 1999; Carlson et al., 1998; Vimpari 
et al., 1995). Other studies have reported that TMD patients on average exhibit lower 
psychopathology scores than is common in several other groups of chronic pain patients, 
but that they are significantly more troubled by psychological distress than pain-free 
individuals (Krogstad et al., 1998; Dahlström, 1993).   
In addition to persistent orofacial pain and dysfunction of the masticatory system, 
TMD patients tend to report higher levels of pain from anatomical sites other than the 
orofacial region and higher levels of somatic symptoms like fatigue and dizziness than do 
healthy controls (Rantala et al., 2003; Vassend et al., 1995). The presence of general 
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somatic and psychological complaints seems to reduce the likelihood of a favourable 
treatment outcome for TMD (Krogstad et al., 1996) as well as constituting a predictor for 
illness severity and disability in untreated TMD (John et al., 2003; Rammelsberg et al., 
2003), suggesting that information of general health complaints should be obtained at the 
onset of treatment, in order to design methods of treatment that better address the needs 
of these patients.
The direction of causality between psychological distress and TMD is a topic of 
discussion. Symptoms of psychological disorders, most notably depression, may be a 
natural consequence of having a chronic pain condition. There is evidence that a 
reduction of TMD symptoms is followed by reduced levels of emotional distress 
(Rammelsberg et al., 2003; Turk et al., 1996). On the other hand, depression has been 
reported to predict the first onset of TMD pain (Sipilä et al., 2001), chest pain and 
headache (von Korff et al., 1993). Moreover, some affective and nociceptive pathways 
coincide anatomically, and the neurotransmitters serotonin and norepinephrine are 
involved in nociception as well as depression and anxiety (Dersh et al., 2002). It has been 
suggested that at least in some groups of chronic pain patients a trait of susceptibility to 
both pain and psychological symptoms may exist (von Korff & Simon, 1996), perhaps 
due to an imbalance of the neurotransmitters involved in both conditions (Dersh et al., 
2002). Recently, a prospective study reported that genetic variants of the adrenergic ȕ2
receptor may influence both psychological characteristics (i.e., anxiety, depression, and 
somatization), blood pressure level, and the risk of development of TMD in females 
healthy at baseline (Diatchenko et al., 2006a).
Likewise, the direction of causality between general somatic complaints and 
TMD is unknown. In particular, similarities between TMD and the fibromyalgia 
syndrome (FMS), a diagnostic entity sharing some of the symptoms that are quite 
common in TMD, e.g., widespread pain, fatigue, sleep disturbances, and psychological 
distress (Wolfe et al., 1990), has been the topic of much debate (Dao et al., 1997; Plesh et 
al., 1996). These illnesses, along with chronic fatigue syndrome (CFS) and irritable 
bowel syndrome (IBS), are by some researchers regarded as different manifestations of 
an underlying, common functional somatic syndrome, a construct describing medically 
unexplained persistent symptoms from multiple organs, often severely compromising the 
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individual’s daily life (Aaron et al., 2000; Barsky & Borus, 1999). The term “functional” 
in medical terms denotes a condition for which no physiological cause has been 
identified, and the etiology of functional somatic syndromes awaits further elucidation. 
Furthermore, the suggestion that relatively different clusters of symptoms, e.g., TMD 
versus IBS, are indicators of a common condition, has met with critique (Moss-Morris & 
Spence, 2006).
One limitation of previous research is the failure to account for the possible 
influence of personality traits on general symptom report. This is unfortunate, given the 
numerous and well-known studies of reporting bias related to high levels of N (Gatchel & 
Weisberg, 2000; Ellington & Wiebe, 1999; Costa & McCrae, 1992). 
Another limitation of previous studies is the lack of control for the impact of acute 
pain sensitivity on general symptom report. One’s present pain level is likely to affect the 
retrospective report of symptoms. High pain levels at present may result in an 
overestimation of previous or current complaints. As chronic pain patients tend to exhibit 
increased acute pain sensitivity compared to pain-free controls (Staud et al., 2005; Sarlani 
& Greenspan, 2003), subjective reports of health variables may be unduly biased in these 
patient groups.
1.5 Pain sensitivity in TMD patients  
1.5.1 The central sensitization model 
Elevated acute pain sensitivity, generalized as well as at focal tender areas, is one of the 
cardinal symptoms of most musculoskeletal pain disorders (e.g., Staud, 2005) including 
TMD (Sarlani & Greenspan, 2003). According to the theoretical work of Maixner and 
coworkers (Fillingim et al., 1996; Maixner et al., 1995), the altered pain sensitivity of 
TMD patients may result from dysfunctional CNS pain regulatory systems. It is still not 
known whether changes in pain sensitivity are causes or consequences of chronic pain. 
Recent studies have reported that initially pain-free individuals characterized by high 
sensitivity to acute pain may be at risk for developing chronic pain problems following 
surgical procedures, amputation, or other pain-producing events (Edwards, 2005). 
Moreover, generally healthy individuals with high sensitivity to experimental pain tend to 
report higher levels of minor daily pain complaints, e.g., headache, back pain, compared 
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to less sensitive individuals (Edwards, 2005). In individuals presenting with acute 
symptoms of TMD, high current pain levels as well as high pain levels during the last 
three months has been predictive of chronic TMD (Epker et al., 1999).
Several current theories of the development of chronic craniofacial pain 
emphasize the pathogenic role of central sensitization, i.e., increased firing rates or 
lowered firing thresholds of CNS neurons. Clinical signs of central sensitization are 
mainly hypersensitivity (i.e., an increased pain response to noxious stimuli) and allodynia 
(i.e., a pain response to non-noxious stimuli). Physiochemical processes involved in 
central sensitization have been studied mainly at the dorsal horn of the spinal chord and 
the brainstem subnucleus caudalis (Woolf & Salter, 2000; Svensson & Graven-Nielsen, 
2001; Bendtsen, 2000; Sessle, 2000). However, cortical areas may also be sensitised, i.e., 
through expansion of the somatosensory receptive fields (Flor, 2003). It is assumed that 
local events such as trauma, inflammation, or overload, may generate increased afferent 
traffic to the spinal chord and brainstem and thus sensitize central neurons in biologically, 
e.g., genetically, vulnerable individuals (Edwards, 2005; Sessle, 2000). In severe cases, it 
is possible that prolonged peripheral input may establish abnormal central activity that is 
no longer dependent on peripheral stimuli, and that may exaggerate nociceptive signals 
from parts of the organism outside of the original painful or injured area, generating a 
tendency to experience symptoms from multiple organs or widespread pain syndromes 
like FMS (Vierck, 2006). As pain sensitivity and psychological distress are mediated by 
some of the same biochemical substances (Dersh et al., 2002; Diatchenko et al., 2006b), 
alterations in central pain pathways may affect the distress level of the individual. Thus, it 
is theoretically not inconceivable that the central sensitization model may account for the 
compromised psychological function in many chronic pain patients, although direct 
evidence of the influence of many of the physiological and chemical processes assumed 
to be involved is still lacking. The investigation of this highly complex neuroplastic 
process is still in its infancy. Given the many spinal and cortical structures assumed to be 
involved in these changes, these theories seem to be in accordance with suggestions 
(Fillingim et al., 1996; Maixner et al., 1995) that TMD is related to maladaptive 
emotional, physiological and neuroendocrine responses to physical and psychological 
stressors.
16
Studies of pain sensitivity in TMD have mostly concentrated on stimulation while 
the participants are resting. However, as most TMD patients report increased pain during 
orofacial activity like chewing or yawning (Sessle et al., 1995), pain stimulation at close 
proximity to masticatory load may provide a fuller picture of the patients’ everyday 
difficulties and level of suffering. 
A recent study of FMS patients reported no group differences between cases and 
controls in heat and pressure pain sensitivity at baseline. However, relative to pain-free 
controls, the FMS group reported lower pain thresholds at several anatomical sites after 
isometric exercise (Staud et al., 2005). These results were interpreted as evidence of 
central sensitization and/or dysregulated endogenous pain control mechanisms in FMS 
(Staud et al., 2005). The similarities between TMD and FMS, e.g., musculoskeletal pain 
of unknown origin, fatigue, and psychological distress (Plesh et al., 1996), indicate that 
similar mechanisms of altered pain sensitivity may characterize these patient groups.
Central sensitization due to increased nociceptive afferent traffic may not be the 
only explanation of chronic pain conditions. The organism is able to attenuate pain 
through complex endogenous control mechanisms originating in the cortex and 
brainstem, acting on nociceptive traffic at several sites of the spinal chord and brainstem 
(Millan, 2002). The periaqueductal grey matter (PAG), a midbrain structure, plays a 
central role in modulation of nociceptive signals, receiving input from lower levels of the 
spinal chord as well as higher levels of the CNS such as the hypothalamus, the amygdala, 
and the prefrontal cortex (Millan, 2002).
1.5.2 The cardiovascular – pain sensitivity model 
One endogenous pain regulatory mechanism subjected to increasing scientific interest the 
last two decades is the analgesic properties of cardiovascular system responses. There is a 
considerable overlap between CNS regions involved in nociception and control of the 
cardiovascular system, e.g., the hypothalamus, the PAG, and the n. tractus solitarus 
(NTS) of the brainstem (Bruehl & Chung, 2004).  Accumulated research has 
demonstrated a relationship between elevated cardiovascular (CV) parameters, e.g., 
arterial blood pressure, and attenuated pain sensitivity (e.g., Bruehl et al., 1999; France 
1999). Several hypotheses regarding mechanisms behind the relationship between the CV 
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system and pain sensitivity have been suggested. Suggestions of trait-like hypoalgesia 
being part of a predisposition for hypertension through alterations in the function of the 
hypothalamic paraventricular nucleus (France, 1999) do not seem to explain this 
phenomenon in full, as manifest hypertension or genetic risk for hypertension is not 
necessary for CV-related hypoalgesia to occur (Al’Absi & Petersen, 2003; Al’Absi et al., 
2000). Moreover, explanations based on opioid release triggered by baroreceptor 
stimulation during elevated blood pressure in humans have been questioned (Bruehl et 
al., 1999; France, 1999). A model in which stimulation of arterial baroreceptors during 
elevated arterial pressure induce hypoalgesia as well as general CNS sedatory effects, has 
been supported in animals and humans (Ghione, 1996). Acute pain is assumed to 
generate elevated arterial pressure through sympathetic activation. Elevated arterial 
pressure stimulates the sinoartic baroreceptors, which triggers descending pain inhibitory 
responses. The pain level is consequently reduced, in turn returning the arterial pressure 
to baseline. The NTS functions as an interface between the sensory and the autonomic 
systems, and is presumed to play a major role in this process (Bruehl & Chung, 2004).   
Another explanation relates to the function of the PAG, which coordinates 
analgesic and cardiovascular responses during threat and trauma (Bandler & Shipley, 
1994). Hypoalgesia may be an integrated part of active coping responses. Pain, being a 
signal of injury or illness, triggers integrated response patterns that facilitates fight-or-
flight behaviour, i.e., through increases in pressor responses coupled with descending 
inhibitory pain mechanisms (Bandler & Shipley, 1994; Green et al., 2006). The function 
of this integrated response pattern during ongoing pain is unknown (Green et al., 2006). 
Dysregulation of this negative feedback process may be responsible for lack of 
CV-modulated pain sensitivity in chronic pain patients (Maixner et al., 1997; Bruehl et 
al., 2002). Both low-back pain (Bruehl et al., 2002) and TMD patients (Bragdon et al., 
2002; Maixner et al., 1997) do not seem to demonstrate the pain-attenuating effects of 
increased CV levels. There is evidence that chronic pain groups are susceptible to 
hypertension (Bruehl et al., 2005), and that baroreceptor stimulation produces increased 
experimental pain in chronic low back pain (Brody et al., 1997).  The physiological 
processes underlying this proposed dysregulation have yet to be discovered, although 
variants of adrenergic ȕ2 receptors involved in both development of TMD, affective 
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distress, and blood pressure responding may be genetically transmitted (Diatchenko et al., 
2006a).
Moreover, it is not known if all types of experimental pain stimulation are related 
to CV responding (Poudevigne et al., 2002). Previous studies have employed ischemic 
and thermal pain (Bragdon et al., 2002; Maixner et al., 1997), whereas pressure pain, 
which is assumed to be more similar to the clinical pain suffered by TMD patients, has 
not been investigated in relation to CV responding in chronic pain patients.
Recently, it has been suggested that the link between the CV system and pain 
sensitivity extends to all emotional stimuli, i.e., that increased CV responding is related to 
a general dampening of emotional responses to environmental stimuli in an attempt to 
reduce the impact of intense stimuli and facilitate adaptation to chronic, intense 
emotional stimuli (Pury et al., 2004). These suggestions seem to be compatible with the 
hypothesis of PAG-coordinated response to stress and challenges described above 
(Bandler & Shipley, 1994). So far, support for this hypothesis has been demonstrated in 
one study (Pury et al., 2004), but refuted in another (Nyklicek et al., 2005).
1.6 Focal or generalized psychophysiological responses in TMD patients
According to the diathesis-stress hypothesis of musculoskeletal disorders (Flor et al., 
1990), hyperresponsivity of the muscles to various types of stress, i.e., emotional or 
environmental challenges, may be one of the factors accounting for the development or 
maintenance of musculoskeletal pain once a diathesis to respond with a specific body site 
or system has been established. Regarding TMD in particular, symptoms of tenderness 
and pain of the orofacial muscles in TMD patients have generated studies of 
electromyographic (EMG) activity at rest or during various cognitively or emotionally 
challenging tasks. However, the results of EMG studies of the orofacial region of TMD 
patients are conflicting (e.g., Flor et al., 1992; 1991; Katz et al., 1989; Schroeder et al., 
1991). In addition, reduced EMG activity of muscles at painful regions has also been 
observed and interpreted as an adaptive mechanism to protect an inflamed or injured 
structure from movement (Lund et al., 1991). Moreover, the narrow focus on EMG as the 
preferred method for detecting physiological changes of relevance for the development or 
maintenance of chronic pain conditions ignores the multitude of central, systemic and 
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local mechanisms that may be involved in this process (Sessle, 2000). Relatedly, if 
central sensitization plays a role in the development of TMD, one would expect that these 
patients exhibit hyper-responsiveness to at least some pain stimuli. However, studies of 
focal and generalized physiological reponses to pain stimulation are scarce.  
In addition, individual differences in response to the experimental tasks have 
largely been ignored in previous psychophysiological studies of TMD. The importance of 
taking individual affective responses to the tasks into consideration was illustrated in a 
study by Ohrbach et al. (1998), who found that EMG and electrodermal differences 
between TMD patients and controls to be attributable to affective differences and not the 
stressful experimental manipulations. This point seems particularly important given the 
discrepancy between few or uncertain physiological findings and sometimes severe levels 
of psychological suffering in TMD patients (Dworkin, 1995). Assessments of affective 
distress during environmental challenges may provide information valuable for 
psychological treatment of TMD patients presenting with excessive levels of 
psychological distress.
1.7 Exposure / acute pain events 
The stomatognathic system is involved in numerous activities that may contribute to 
chronic pain in biologically or psychologically vulnerable individuals. The role of 
occlusal factors is controversial (Sessle et al., 1995). Regarding parafunctions, research 
interest has mainly concentrated on bruxism: some studies have found a relationship 
between bruxism and TMD (e.g., Manfredini et al., 2003), while others have not (e.g., 
Lobezzoo & Lavigne, 1997). Dental procedures like third molar extraction may also 
contribute to development of TMD (Huang & Rue, 2006). 
 These mictrotraumatic muscular events may contribute to chronic pain via acute 
pain that causes alterations in the biochemical characteristics of the orofacial muscles 
(Svensson & Graven-Nielsen, 2001). Microtrauma may release biochemical agents, e.g., 
serotonin and substance P, which act upon local nociceptors, increasing the afferent 
traffic into the CNS and thus contributing to the central sensitisation process (Svensson & 
Graven-Nielsen, 2001). This process may be enhanced in genetically vulnerable 
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individuals (Diatchenko et al., 2006a). However, the paucity of research renders this 
hypothesis somewhat speculative. 
1.8 Study objectives    
This study aims at elucidating characteristics which differentiate TMD patients and pain-
free controls.
The comprehensive personality structure of TMD patients is compared with that 
of healthy controls in order to generate information relevant for future treatment 
interventions. Psychological and somatic health complaints in TMD patients are 
compared with those of healthy controls with statistical control for the impact of 
personality traits and pain sensitivity.
Focal and generalized pain sensitivity effects of isometric contraction of the jaw 
in TMD patients and healthy controls are investigated, and the CV-pain relationship is 
extended to pressure pain stimulation. In addition, the CV-related modulatory effects on 
pressure pain and emotional responding are studied in a group of healthy women.  
Finally, the present thesis compares focal as well as systemic physiological 
responding to cognitive tasks, orofacial muscular load, and experimental pain stimulation 
in TMD patients and healthy controls. Measurements of affect are obtained in order to 
gain a fuller picture of the TMD patients’ responses to environmental challenges.
The following topics were examined in the papers: 
x Whether there were differences in personality traits and general health complaints 
between the TMD patients and healthy controls (Paper I) 
x Whether there were differences in experimental pain sensitivity after orofacial 
muscular contraction, and whether the association between pain sensitivity and 
cardiovascular responding was different in TMD patients and healthy controls 
(Paper II) 
x Whether there were differences in focal and systemic psychophysiological 
responses to painful and non-painful experimental tasks in TMD patients and 
healthy controls (Paper III)  
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x Whether there was evidence of a general emotional dampening process in relation 
to cardiovascular responding in normotensive, healthy women (Paper IV) 
2 Material and methods
2.1 Design
The research questions were studied in a cross-sectional design. In Papers I-III the design 
is mixed, with both between-group and within-group comparisons. In paper IV, the study 
has a within-group design.
2.2 Subjects
2.2.1 Papers I-III 
Twenty-five female patients with TMD and 25 healthy females matched for age, level of 
education, smoking, and exercise participated in this study. The TMD patients underwent 
a clinical examination and were diagnosed according to the RDC-TMD (Dworkin & 
LeResche, 1992) by the research staff physiotherapist at the Dental Faculty, University of 
Oslo. Exclusion criteria (self-reported) were other chronic illnesses than TMD (e.g., 
rheumatic, vascular, or psychiatric disorders), pregnancy, and inability to understand 
spoken and written Norwegian. Exclusion criteria (self-reported) specifically targeting 
other orofacial-related illnesses than TMD were rheumatoid arthritis, temporal arthritis, 
trigeminal neuralgia, parotitis, and sinusitis.  
All subjects received written information of the investigation, and all signed an 
informed consent before the experiment. They were informed that they were free to 
withdraw from the experiment at any time. The experiment was conducted according to 
the Helsinki Declaration, and approved by the regional Research Ethics Committee. All 
subjects received NOK 500 (approximately USD 70-80) for their participation. 
 See each paper for demographic information of the participants. 
 See Table 1 for the tenderness to palpation score for the TMD group. Only the 
most prominent muscles are listed, as some of the craniofacial muscle sites, e.g., the 
lateral pterygoid and posterior styloid muscles, are very difficult to palpate and may not 
be valid for the diagnostic process (Dworkin & LeResche, 1992).
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Table 1. Tenderness to palpation in selected craniofacial muscles in TMD patients  
                  Tenderness score 
Muscle site    None    Mild Moderate Pronounced
R. temporalis posterior 13 (59.1%) 5 (22.7%) 4 (18.2%) -----------
L. temporalis posterior 15 (68.2%) 4 (18.2%) 2 (9.1%) 1 (4.5%) 
R. temporalis anterior 8 (38.1%) 4 (19%) 2 (9.5%) 7 (33.3%) 
L. temporalis anterior 11 (52.4%) 4 (19%) 4 (19%) 2 (9.5%) 
R. masseter profundus 3 (15%) 6 (30%) 6 (30%) 5 (25%) 
L. masseter profundus 5 (25%) 5 (25%) 8 (40%) 2 (10%) 
R. masseter superficialis 
(middle) 
1 (4.8%) 5 (23.8%) 7 (33.3%) 8 (38.1%) 
L. masseter superficialis 
(middle) 
6 (28.6%) 7 (33.3%) 2 (9.5%) 6 (28.6%) 
R. sternocleidomastoideus 6 (28.6%) 1 (4.8%) 6. (28.6%) 8 (38.1%) 
L. sternocleidomastoideus  5 (23.8%) 6 (28.6%) 5 (23.8%) 5 (23.8%) 
The palpation was performed according to the Research Diagnostic Criteria for TMD (N 
= 20-25). 
2.2.2 Paper IV 
Thirty-nine Caucasian women (see Paper IV for demographic characteristics) were 
recruited among graduate students of medicine and psychology of the University of Oslo 
via the students’ mailing lists. Inclusion criteria were age between 20 and 50 years, and 
ability to speak and understand spoken and written Norwegian. Exclusion criteria (self 
reported) were known hypertension, chronic pain, general chronic somatic or mental 
health problems, pregnancy, and use of regular medication apart from oral contraceptives. 
The decision to study only females in Paper IV was based on the wish to investigate 
further some of the results of Paper II, in which the participants were all women.  
        The study was conducted in accordance with the Helsinki Declaration and approved 
by the regional Research Ethics Committee. All subjects gave their informed consent to 
the participation, and were informed that they were able to withdraw from the experiment 
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at any time. All subjects received a gift-voucher at the price of 250 NOK (approximately 
USD 35-40) for their participation.
2.3 Psychophysiological experiments
2.3.1 Experimental tasks 
Outlines of the experimental procedures are given in Figures 2 and 3. The order of the 
experimental tasks was not randomized. The rationale for this was to present the least 
painful tasks at the start of the experiment. There were two electrocutaneous pain 
stimulation trials associated with the tracking task, and the isometric contraction was 
expected to generate discomfort or pain in the TMD group. Therefore, these tasks were 
placed at the end of the experimental session. It may be argued that the order of the 
experimental conditions should ideally be counter-balanced to avoid systematic carry-
over effects in psychophysiological studies. However, analyses of the healthy control 
group of the present study revealed that the physiological levels of responding were 
highly similar during the relaxation periods prior to and after the cognitive tasks, 
indicating negligible carry-over effects (Vassend & Knardahl, 2004; 2005).
2.3.1.1 Papers I-III
The subjects were seated in an upright position in a sound-attenuated and electro-
magnetically shielded room (2.8m x 2.9m) with a temperature of 22 qC. The female 
experimenter described the function of the instruments and sensors, without disclosing 
the hypotheses to be tested. The psychophysiological experiment lasted 2-2.5 hours. All 
subjects went through the experimental manipulations in the same order. Behind a one-
way mirror, a research assistant monitored the experimenter and the subject. A female 
experimenter was present in the room with the participants throughout the experiment. 
An outline of the experiment and the data selected for this study are presented in each 
paper.
 After initial instructions, preparation and attachment of electrodes and sensors, 
and a practice trial of pain stimulation, the experiment consisted of the following 
manipulations: a habituation task (reading aloud), a simulated job interview, a 
visuomotoric tracking task, isometric contraction of the jaw, and maximally voluntary 
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contraction of the trapezius and left biceps muscles. Between the experimental tasks, pain 
stimulation trials were performed. 
2.3.1.2 Paper IV
The psychophysiological experiment took place in a sound attenuated and 
electromagnetically shielded laboratory with temperature kept constant at 22° C. The 
subjects were seated in an upright position in a comfortable, upholstered chair. 
 The first 30-40 min. of the experiment consisted of randomized sequences of 
pressure and electrocutaneous pain stimulation. All subjects went through three 
electrocutaneous stimulation trials, three pressure stimulation trials at the right masseter 
muscle, and three pressure stimulation trials at the sternum (equipment and assessment 
procedure as described for Papers I-III). Two-minute resting periods between each trial 
were provided to ascertain that the physiological responses returned to baseline before the 
next trial.
After the initial series of pain stimulation and a relaxation period, the subjects 
went through the simulated job interview described in Papers II and III. After the 
interview, pressure pain stimulation was performed twice at the right masseter muscle.  
2.3.2 Pain stimulation 
The assessment of pain is complicated by the fact that, in contrast to other sensory and 
perceptual processes, nociception is not triggered by a unique type of stimulation at a 
unique anatomical site. Auditory perception, e.g., is triggered by the stimulation of the 
sensory organ (the ear) with physical energy (sound waves). In contrast, almost every 
anatomical structure may respond to nociceptive stimulation, and several types of 
stimulation (e.g., pressure, heat, chemicals) may trigger this process. In addition, the 
affective component of the pain experience is probably more pronounced than of other 
types of perception. There exists no golden standard for the assessment of this affective 
component, which in addition shows considerable individual variability (Price, 1999). 
These unique features make it difficult to obtain objective measurements of the pain 
experience, although there is some recent evidence that it may be possible (see Nielsen, 
2007). However, pain stimulation may be readily quantified in a laboratory setting, thus 
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permitting control over at least one part of the pain perception process. Standardization of 
stimulation may be relatively less relevant in clinical settings, but is pivotal in studies 
aiming at determining the mechanisms of pain and their correlation with other biological 
or psychological variables. 
It may be argued that the experience resulting from experimental pain stimulation 
does not correspond completely to the clinical type of pain that is ongoing and often 
induced or exacerbated by movement in chronic musculoskeletal pain patients. 
Assessments of naturally occurring pain during activities of daily life could be described 
as having stronger ecological validity than experimentally induced pain stimulation. 
However, there are two reasons why the present study chose a laboratory setting with all 
participants maintaining the same seated position. First, this procedure was necessary to 
permit quantification of the pain stimulation. Second, the methods of physiological 
recordings chosen require the participants to refrain from vigourous movement.  
Sensory threshold, pain threshold and tolerance of electrocutaneous stimulation:
Electrocutaneous stimulation (ES, 50 ms pulses, 4 per s) was administered to the dorsal 
area of the subjects’ left hand through two electrodes with a diameter of 5 mm and a 
center-to-center distance of 20 mm by a Grass S48 Stimulator (Grass Technologies, 
Rockland, MA, USA) with a Grass stimulation isolation unit (SIU5B) and a Grass 
constant current unit (CCU1A) attached. All instruments provided electrical isolation of 
the subjects. The skin of the subjects’ left hand was cleansed with alcohol and Ag/AgCl 
paste applied to the electrodes. The maximum voltage was 150 V. The stimulation was 
controlled by the experimenter by using an intensity control starting at 0 V.  
Electrocutaneous stimulation is widely used, easy to apply, and repeatable 
(Gracely, 1994). This method induces a sharp, itching type of pain by stimulating 
superficial skin nociceptors. The subjects were instructed to report immediately when 
they first noticed a sensation or «itching», and when it became painful, and pressed a 
hand-held button the moment they evaluated the pain as being so intense that they wanted 
to interrupt the stimulation.  
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In addition to a pre-test to familiarize the subjects with the stimulation procedure, 
one trial of ES was delivered to each subject before and after every experimental 
condition and during the distraction task, totalling six trials.
Pain threshold and tolerance of pressure algometry: Pressure pain (PP) was induced by a 
pressure algometer (Somedic, Sollentuna, Sweden), with a 10 mm diameter stimulation 
probe at the end of a force transducer. The rate of pressure increase is standardized by 
visual feedback provided by the algometer and was set at 50 kPa/s. This rate of pressure 
increase was chosen to avoid prolonged pressure to the tissue of the participants and to 
avoid fatiguing the experimenter. Despite this relatively steep rate of pressure increase, 
there was a high test-retest reliability between pain stimulation sessions, indicating that 
the experimenter had no difficulties reading the treshold values: The two first pain 
stimulation trials (before and after the reading task) were not intended to be affected by 
the experimental manipulations, and were used to calculate the test-retest reliability 
(Table 2).
Table 2. Pearson’s correlations of the first and second pressure pain stimulation trial. 
TMD (N = 25) Controls (N = 25) 
Pain threshold, masseter  .78 ***  .80 *** 
Pain tolerance, masseter  .83 ***  .88 *** 
Pain threshold, sternum  .88 ***  .84 *** 
Pain tolerance, sternum  .96 ***  .83 *** 
 *** = p < .001 (two-tailed).
Pressure algometry was applied perpendicularly to the belly of the right masseter 
muscle, approximately 2 cm anterior to and 1 cm above the angle of the jaw. The 
decision to stimulate the right masseter was based on several studies reporting no 
statistical site difference in pressure pain thresholds in TMD patients (Isserlée et al., 
2002; Svensson et al., 1995; McMillan & Blasberg, 1994; List et al., 1993). Pressure 
stimulation on the sternum provided a non-muscular reference. The subjects were asked 
to raise their right index finger when the pressure became painful, and to press a 
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terminate-test-button when it became so intense that they wanted to interrupt the 
stimulation.  
In addition to a pre-test to familiarize the subjects with the stimulation procedure, 
one trial of PP was delivered to each subject before and after every experimental 
condition, totalling five trials. Unpublished pilot studies (Cecilie Røe, National Institute 
of Occupational Health, personal communication) have demonstrated that there is no risk 
of increased tenderness influencing experimental pressure pain sensitivity if repeated 
trials of stimulation of a particular anatomical site are separated by at least 2 min. In the 
present study, the interval between stimulation trials of the same site was always greater 
than 2 min.  
Pressure algometry induces pain of a different quality than ES does. The type of 
pain induced is deep/muscular pain, although skin nociceptors are also stimulated 
(Gracely, 1994). The sensations are aching, cramping and not sharply localized. This 
similarity to the pain seen in many chronic musculoskeletal pain conditions have led to 
pressure pain being regarded as a somewhat more «natural» type of pain (Harris & 
Rollman, 1983).    
Masseter muscle pressure stimulation is probably the only non-invasive method 
currently available for induction of a type of pain that resembles the clinical pain of TMD 
patients (Fischer, 1998).  One of the chief criteria for the TDM diagnosis is palpation 
tenderness of orofacial muscles. Hence, in this study that partly aimed at explorations of 
hypothesized mechanisms of TMD development, pressure stimulation of the masseter 
muscle was deemed appropriate. In order to test the hypothesis that central sensitization 
is characteristic of many chronic pain patients and may be demonstrated by altered pain 
sensitivity also in non-muscular regions and through stimulation methods unrelated to 
muscular pain, pressure stimulation of the sternum and electrical stimulation of the left 
hand were chosen.
Spontaneous or on-going pain: Before every pain assessment, the subjects reported the 
intensity of spontaneous pain that was not induced as part of the experimental procedure 
(e.g., facial pain, headache) using an electronic Visual Analogue Scale. 
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2.3.3 Psychophysiological recording 
The following psychophysiological parameters were recorded continuously during the 
entire experimental session.  
Cardiovascular parameters: Mean arterial pressure (MAP) and heart rate (HR) 
were continuously monitored by the Penaz method (Finapres, Ohmeda 2300, Englewood, 
CO, USA).
 Skin blood flux (SBF) responses were recorded with a Perimed Multichannel 
Laser Doppler System (PeriFlux 4001 Master, Perimed, Järfälla, Sweden). Miniature 
probes (Perimed, Järfälla, Sweden) were attached on the left masseter anterior to the 
electromyography electrodes (see below) and on the ventral side of the left thumb.  
Muscle activity: Surface electromyography (EMG) was recorded from the left m. 
masseter, the left m. biceps bracchius, and bilaterally from the mm. trapezii (Paper III). 
Only EMG responses from the masseter muscle and the left trapezius are presented, due 
to the data from the right trapezius being influenced by movements of the right arm and 
hand during the experimental manipulations.  
As the EMG and LDF measurements are superficial and the probes do not exert 
pressure on the skin, there is probably very little risk of interference between EMG 
electrodes and LDF probes.
All signals were AD-converted (12 bit A/D card, AT-MIO-16E-10, National 
Instruments, Austin, Texas, USA) with a sampling frequency of 2000 Hz, stored and 
reduced by LabView (National Instruments, Austin, TX, USA). 
Papers II-IV provide detailed description of types and placements of electrodes 
and sensors as well as signal amplification. 
2.3.4 Affect measurements 
2.3.4.1 Paper III
At the start of the experiment, after the job interview, and after the experiment was 
finished, the subjects filled in the state-version of the Spielberger State-Trait Personality 
Inventory (STPI, Spielberger, 1979; Håseth & Spielberger, 2000).
29
After each experimental task, the subjects rated their affective experiences to the 
task on 23 paper-and-pencil Visual Analogue Scales (VAS), ranging from «not at all» (at 
0 mm) to «maximally» (at 100 mm). (See Paper III for details.)  
2.3.4.2 Paper IV
Upon entering the laboratory, before the instructions for the job interview were given and 
at the end of the entire experimental session, the subjects filled in the state-version of the 
State-Trait Personality Inventory (STPI; Spielberger et al., 1979; Håseth & Spielberger, 
2000). After the pain stimulation sequence in the first part of the experiment and after the 
two pressure pain trials after the job interview, the subjects rated their affective 
experiences to the pain (Price, 1999). The reports, averaged into four indices, were 16 
paper-and-pencil VAS, ranging from «not at all» (at 0 mm) to «maximally» (at 100 mm) 
(see Paper IV for details). 
At the end of the experiment, the subjects rated the simulated job interview in a 
similar way (see Paper III for details). 
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Time       Papers Condition       
0 min 
45
min 
70
min 
85
min 
100-
120
 min 
  III 
  I, II 
  I, II, III 
  II, III 
  III 
  III 
  III 
  II 
  I, II, III 
  II, III 
  II, III 
  II
  II 
  III
  III 
  III 
  III 
  III 
  III
  III
  II, III 
  II 
  II 
  III 
  III 
Informed consent, general instructions and preparation      
Practice of pain testing 
STPI-State
Report of clinical pain                                                                  
Pain testing
Relaxation
Reading aloud                                                                              
Recovery
Report of task-related affective experiences
Report of clinical pain                                                                  
Pain testing 
Relaxation
Preparation for simulated job interview 
Simulated job interview 
Report of clinical pain 
Pain testing 
Recovery
Report of task-related affective experiences 
STPI-State
Relaxation
Visuo-motoric tracking 
Electrocutaneous pain testing 
Visuo-motoric tracking 
Recovery
Report of task-related affective experiences 
Report of clinical pain 
Pain testing 
Relaxation
Report of clinical pain 
Isometric contraction of jaw-closing muscles 
Report of clinical pain 
Pain testing 
Maximally voluntary contraction of trapezius muscles 
STPI-State
Figure 2. Outline of the experimental procedure and the variables analyzed, papers I-III. 
Physiological recordings were made continuously. Pain testing: electrocutaneous 
stimulation of the dorsal left hand and pressure pain stimulation of the right masseter 
muscle and the sternum. After the experimental session, questionnaires on demography, 
general health complaints, and personality traits were filled in.  
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Time Condition
0 min 
45 min 
70 min 
Informed consent, general instructions and preparation 
Practice of pain testing 
STPI-State
Randomized trials of pain testing separated by 2 min relaxation periods 
Report of pain-related affective experiences 
STPI-State
Relaxation
Preparation for simulated job interview 
Simulated job interview 
Pressure pain testing at masseter 
Relaxation
Pressure pain testing at masseter 
Report of pain-related affective experiences 
Report of interview-related affective experiences 
STPI-State
Figure 3. Outline of the experimental procedure, paper IV. Physiological recordings were 
made continuously. Pain testing: electrocutaneous stimulation of the dorsal left hand and 
pressure pain stimulation of the right masseter muscle and the sternum. After each pain 
stimulation trial, reports of sensory and affective experience were made by electronic 
VAS. After the experimental session, questionnaires on demography, general health 
complaints, and personality traits were filled in.  
2.4 Questionnaires – Paper I
The NEO-PI-R (Costa & McCrae, 1992; Martinsen et al., 2003) was administered to 
assess personality traits. The NEO-PI-R was developed on basis of the FFM, and is one 
of the most widely used personality inventories. It is reported to have high reliability and 
validity, and has been validated both cross-culturally, by self-ratings, and by ratings by 
peers and spouses (Wiggins, 1995). It has also been validated against other personality 
inventories, like the California Q-Set and the Eysenck Personality Questionnaire (Hogan 
et al., 1997). 
Each of the five factors of the FFM consists of six sub-scales, or facets (see paper 
I). The items of the questionnaire are presented as statements, e.g. «I am not a person that 
worries», or «I like being surrounded by people». Responses are made on a five-point 
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Likert scale ranging from «Strongly disagree» to «Strongly agree». The full version of 
the NEO-PI-R, consisting of 240 items, was used in this study.   
The Social Desirability Scale (Crowne & Marlow, 1960; Rudmin, 1999) was used 
to assess self-presentation bias. It consists of 33 items, which are presented as questions, 
e g., “I never resent being asked to return a favour”. Responses are made by checking one 
of two alternatives, “Correct” or “Wrong”.  
The Spielberger State-Trait Personality Inventory (STPI, Spielberger, 1979; 
Håseth & Spielberger, 2000) was used to assess situational affect and stable trait-like 
affective responses. Both the state and the trait version consist of 40 items each, and 
measures anxiety, curiosity, anger and depression. Responses are made on a four-point 
Likert scale ranging from “Not at all” to “Very much”.
The Symptom Checklist 90-R (SCL-90-R) (Derogatis, 1983; Vassend & Skrondal, 
2003) was used to assess emotional distress symptoms. It comprises nine sub-scales: 
somatization, obsessive-compulsive tendencies, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychotisism. In total, the SCL-
90-R consists of 90 items. All items are questions, e.g., ”During the last 7 days, how 
often have you been troubled by persistent negative thoughts?”. Responses are made on a 
five-point Likert scale ranging from ”Not at all” to ”Very much”. 
The Health Complaint Report (HCR) was administered to obtain information on 
somatic and psychological health complaints. The HCR was designed at the Norwegian 
National Institute of Occupational Health for use in working populations 
(Steingrimsdottir et al., 2004). It measures both severity and duration of musculoskeletal 
pain (12 items), gastrointestinal symptoms (6 items), psychological distress (5 items), 
allergy (3 items), and common cold (2 items) during the past 14 days. For severity of 
symptoms, responses are made on a four-point Likert scale ranging from ”not troubled at 
all” to ”very troubled”. Indices based on the mean severity scores multiplied with mean 
duration scores of the musculoskeletal symptoms (MSI), gastrointestinal symptoms (GI), 
allergic complaints (AI) and upper airway infection complaints (UAII) were computed.  
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2.5 Data reduction
All signals were AD-converted, recorded, stored and reduced in a computer (Lab View, 
National Instruments, Austin, TX, USA). The data from the experimental tasks were 
averaged for one-minute, two-minute, or three-minute periods (see individual papers for 
specific information). The data recorded during ES were averaged for one-second epochs 
at the threshold and tolerance levels. The data recorded during the PP were averaged for 
the entire stimulation period. 
 See individual papers for information concerning the aggregation of pain 
stimulation trials and calculation of physiological change scores.
   
2.6 Statistical analyses 
The statistical analyses were performed using SPSS, release 12 (SPSS Inc., Chicago, IL, 
USA). See Table 3 for an outline of and each paper for details on statistical tests. 
 In Paper II, there were cases of large standard deviations relative to mean 
experimental pain values. The experimental pain data presented in that paper were 
therefore logarithmically transformed to allow the use of parametric statistics.  
A 5% significance level was adopted. This increases the risk of Type I errors. 
However, a too stringent significant level would increase the risk of Type II errors, 
reducing the chances of identifying relationships worthy of further study.  Relatedly, 
adjustments for multiple tests, e.g., Bonferroni corrections, reduce the risk of Type I 
errors, but increase the risk of Type II errors. The wish to avoid Type II errors was 
pronounced in this study, which was partially intended to be hypothesis generating. 
Therefore, as recommended by Rothman (1990) and Perneger (1998), no adjustments for 
multiple tests were done.   
 Significance tests are able to provide information on whether there is a 
statistically significant relationship between two or more variables. However, they to not 
describe the strength of these relationships, which may be more informative and more 
important in clinical practice. Therefore, the present study presents effect sizes of most 
major statistical associations.  
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Table 3. Statistical analyses used in Papers I-IV 
Research question Statistical analysis Paper
Group differences in personality 
traits 
Independent samples t-test I
Group differences in subjective 
health complaints 
Independent samples t-test, 
multivariate regression 
I
Association between Neuroticism 
and TMD characteristics
Pearson’s correlation I
Group differences in pain 
sensitivity
Independent samples t-test II
Changes in pain sensitivity across 
the experiment 
Repeated-measures ANOVA II
Associations between CV 
responding and pain sensitivity 
Pearson’s correlation, partial 
correlation 
II
Spontaneous, non-experimental  
pain
Mann-Whitney U-test II
Group differences in EMG Mann-Whitney U-test III
Group differences in LDF, MAP, 
and HR 
Independent samples t-test III
Changes in EMG, LDF, MAP, 
and HR across the experiment 
Repeated-measures ANOVA III
Group differences in affective 
responding
Independent samples t-test III
Changes in affective responding 
across the experiment 
Repeated-measures ANOVA III
Changes in MAP and HR across 
the experiment 
Related samples t-test, repeated-
measures ANOVA 
IV
Changes in pain sensitivity across 
the experiment 
Related samples t-test, repeated-
measures ANOVA 
IV
Changes in affective responding 
across the experiment 
Repeated-measures ANOVA IV
Associations between CV 
responding and pain sensitivity 
Pearson’s correlation, partial 
correlation 
IV
Associations between CV
responding and affect variables 
Pearson’s correlation IV
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3 Results 
3.1 Paper I   
Mohn C, Vassend O., Krogstad, BS, Knardahl, S. Personality traits and subjective health 
complaints in female TMD patients and healthy controls. Submitted.
In Paper I, the following research questions were asked: (1) Do the five personality traits 
of the FFM and their sub-scales differ in TMD patients and pain-free controls? (2) When 
controlling for Neuroticism, self-presentation bias, and pain sensitivity, do TMD patients 
differ from pain-free controls in terms of psychological and non-TMD related somatic 
complaints?  
The TMD patients exhibited a lower level of E and O. In addition, significant 
differences between the TMD patients and the control group with regard to the facets N-
Depression, A-Tendermindedness, and C-Dutifulness were found. 
 There were higher levels of psychological distress and musculoskeletal pain in the 
TMD group relative to the control group. Hence, the typical TMD profile of affective 
distress and extra-craniofacial pain was reproduced. Importantly, these differences were 
maintained after controlling for N, self-presentation bias, and acute pain sensitivity. 
3.2 Paper II 
Mohn C, Vassend O, Knardahl S. Experimental pain sensitivity in women with 
temporomandibular disorders and pain-free controls: the relationship to orofacial 
muscular contraction and cardiovascular responses. In press, Clinical Journal of Pain. 
In Paper II, the following research questions were asked: (1) Do TMD patients report 
lower orofacial pain thresholds at baseline and after isometric contraction of the orofacial 
region relative to pain-free controls? (2) Do TMD patients report lower extra-craniofacial 
pain thresholds after isometric contraction of the orofacial region? (3) Are there 
differential effects of experimentally induced CVR on the sensory detection thresholds, 
the pain thresholds and the pain tolerance in TMD patients and in pain-free controls?   
Relative to the control group, the TMD group exhibited a significantly higher 
electrocutaneous pain threshold and non-significantly lower pressure pain thresholds at 
baseline. After isometric contraction of the jaw, the TMD group exhibited increased 
general pain sensitivity. This did not occur in the control group.
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 An arousing job interview did not significantly affect the subsequent pain 
sensitivity in any group. Significant positive correlations between MAP and pain 
thresholds and tolerance were seen only in the TMD group.
3.3 Paper III   
Mohn C, Vassend O, Knardahl S. Focal and generalized psychophysiological responses 
to cognitive tasks and experimental pain stimulation in female temporomandibular 
disorder patients. Submitted.
In Paper III, the following research questions were asked: (1) When responding to 
cognitive challenges and orofacial muscular contraction, do TMD patients exhibit focal 
orofacial responses or generalized reactivity? (2) Do these psychophysiological responses 
in TMD patients and pain-free controls parallell subjective reports of affective state? (3) 
Compared to pain-free controls, do TMD patients respond differently to experimental 
pain stimulation?  
The cognitive tasks elicited significant MAP, HR, and SBF responses, and, 
overall, these were similar in the two groups. There were significantly lower levels of 
masseter EMG in the TMD group during relaxation, cognitive tasks, and jaw contraction. 
 Apart from a significantly lower masseter EMG in the TMD group during 
ipsilateral masseter pressure pain, there were no group differences in physiological 
responding during experimental pain stimulation.  
 Relative to the controls, the TMD patients were more distressed during the 
experiment, as evidenced by their report of higher levels of state anxiety and depression 
as well as a more negative experience of the job-interview. 
3.4 Paper IV 
Mohn C, Vassend O, Knardahl S. Cardiovascular modulation of pain perception and 
affective responses in normotensive, pain-free women. Submitted. 
In Paper IV, the following research questions were asked: (1) Do CV responses induced 
by a simulated job-interview alter subsequent pain perception? (2) Are there significant 
associations between CV parameters (resting, task-level and change scores) and pain 
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perception? (3) Are there significant associations between CV responding and affective 
responses?
The results from this study do not suggest a strong relationship between CV 
responding and pressure pain sensitivity in normotensive, pain-free women. There were 
only few and isolated findings of associations between CV measures, pain sensitivity, and 
emotional response.  
Several methodological aspects strengthen the validity of this finding. Control for 
menstrual cycle events, weekend-related changes in physiology, and the CV changes 
during pain stimulation was provided. In addition, cardiovascular and pain stimulation 
data obtained at three points during the experiment - before, during, and after the 
arousing intervention - were analysed.
4 Discussion 
There were marked group differences in subjective reports of personality traits and 
psychological and musculoskeletal health complaints. Significant group differences in 
experimental pain sensitivity largely did not emerge at baseline. However, after isometric 
contraction of the jaw muscles, experimental pain sensitivity was enhanced in the TMD 
group. With respect to physiological responding during cognitive tasks, significant group 
differences were observed only for absolute levels of EMG.
4.1 Methodological considerations and limitations 
When interpreting the present data, several limitations must be kept in mind.  
This study is limited by the relatively low number of participants, an issue 
particularly relevant when interpreting the non-significant results of Papers II and III. 
Moreover, the small TMD sample did not permit division into diagnostic subgroups, a 
procedure necessary for generating hypotheses of the pathogenesis of TMD and other 
heterogeneous myofascial pain conditions. Although there was sufficient power to 
reproduce the typical TMD profile of psychological distress and general musculoskeletal 
pain in Paper I, this study may have been somewhat underpowered with respect to 
analyses of pain sensitivity and physiological responding due to possible sub-group 
variation in the TMD group. However, it must be emphasized that there were no clear, 
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non-significant trends in altered CV physiological responding in the TMD group (Paper 
III). This suggests that there really are no differences between TMD patients and controls 
in terms of MAP, HR, and SBF during cognitive tasks and experimental pain stimulation, 
or alternatively, that existing differences may be marginal or of little clinical relevance. 
 The TMD group consisted of clinical and community cases. Population samples 
of TMD may report lower levels of pain severity, suffering, and functional impairment 
(Ohrbach & Dworkin, 1998). There were no such differences in the present study, and the 
pooling of the two samples seems justified. However, the population sample may have 
been too small (nearly half of the clinical sample) for significant group differences to 
emerge.  
 The pain-free status of the participants in the control group was not determined on 
the basis of a diagnostization process according to the RDC-TMD (Dworkin & 
LeResche, 1992), but according to self-report of symptoms. Symptoms and signs of 
TMD, e.g., pain and clicking sounds, are common in the general population, albeit at a 
level that may not be severe enough to warrant the diagnosis of TMD (Rantala et al., 
2004), and it can not be concluded that the current control group consisted of individuals 
completely free of TMD-related symptoms.  
 The experimental conditions were presented in the same order for all participants. 
The participants rested for several minutes between conditions, so carry-over effects 
should be marginal. However, there is a remote possibility that the increased generalized 
pain sensitivity of the TMD patients after the jaw contraction was due to the fact that the 
subsequent pain stimulation was the last in a series of seven trials in addition to the 
muscular contraction itself. The condition assumed to be most physically challenging 
were performed at the end of the experiment, so as to avoid inducing excessive fatigue in 
the participants at an early stage of the experimental procedure. In order to affirm the 
conclusion that jaw contraction is capable of inducing generalized pain sensitivity in 
TMD patients, future studies should have participants perform jaw contraction closer to 
the baseline assessments of pain sensitivity.    
 The local physiological recording may not have been sufficiently sensitive for the 
detection of a higher number of group differences in Paper III. Intra-muscular EMG and 
LDF recordings may provide physiological data of higher sensitivity than superficial 
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recordings. However, needle electrodes and probes are susceptible to movement artefacts. 
Surface recordings of EMG and blood flow were chosen as the cognitive tasks, i.e., 
verbalizing and visuomotoric tracking, were expected to generate movement of the 
orofacial and shoulder region. In addition, this method is not invasive and therefore less 
stressful for the participants.  
The current results are based on studies of women only. Female TMD sufferers 
tend to report more psychological distress and physical symptoms compared to male 
TMD patients (Dao & LeResche, 2002), and women in general have been found to report 
higher pain sensitivity than men (Berkely, 1997). Thus, the results of Papers I and II may 
not generalise to the male TMD population. In addition, it was controlled for menstrual 
cycle events only in Paper IV, thus limiting the generalizability of the results of Paper II 
with respect to acute pain sensitivity.  
MAP and HR were measured by the Peñaz method. Compared to brachial 
sphygmomanometry, the finger pressure method may underestimates absolute arterial 
pressure, but provides accurate measurements of pressure changes (Pickering et al., 
2005), which was one of the aims of the present study. Moreover, brachial 
sphygmomanometry may generate moderate pressure pain in the subjects, risking 
interference with the assessment of the experimental pain sensitivity that was the aim of 
our study. Nevertheless, it must be acknowledged that the MAP is influenced more by the 
diastolic than the systolic pressure, and the systolic pressure seems to be better able to 
predict pain sensitivity (Bragdon et al., 2002; Maixner et al., 1997). That the 
measurements of MAP were not calibrated with pressure values obtained through 
sphygmomanometry is a limitation of the present study.  
4.2 General discussion 
4.2.1 Personality traits and chronic pain 
Reduced levels of E and O in addition to non-significantly elevated N in the TMD group 
were observed. This is a novel finding, as previous research has tended to concentrate on 
N or NA only.
 Based on the relative stability of personality traits in adults, most studies of the 
personality and health relationship assume that personality characteristics in some way 
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are involved in the development of somatic illness even in the absence of evidence for a 
pain-prone personality (Gatchel & Weisberg, 2000). It has recently been demonstrated 
that many inventories used to assess personality traits e.g., the MMPI, are influenced by 
state-related affect and fluctuations in chronic pain intensity (Fishbain et al., 2006). 
However, that study did not investigate the effect of symptom severity on the NEO-PI-R, 
an inventory assumed to be less contaminated by state affect and current health 
complaints than the MMPI (Gatchel & Weisberg, 2000), and that has shown relatively 
strong stability in the face of life events and illness-related changes (Costa & McCrae, 
1992). Therefore, although the present cross-sectional study does not enable causal 
conclusions regarding the personality-pain relationship, it may be argued that E and O 
may be involved in the development or presentation of TMD symptoms.  
A first explanation of such a hypothesized relationship is a direct link between 
personality and TMD development. Based on previous findings of elevated N in the 
absence of pathophysiological variables (Costa & McCrae, 1992; Gatchel & Weisberg, 
2000) this explanation seems unlikely at first glance. However, recent advances in 
neuroscience have identified brain regions and biochemical agents relating to different 
personality traits. In a magnetic resonance imaging (MRI) study, Omura et al. (2005) 
reported that amygdala grey matter concentration correlated differently with N than with 
E.  Furthermore, compared to those low in N, individuals high in N have been found to 
exhibit higher levels of salivary cortisol, suggestive of altered hypothalamic-pituitary-
adrenal (HPA) axis function (Portella et al., 2005). Abnormalities of the HPA axis have 
been reported in chronic widespread pain disorder (McBeth et al., 2005). The possibility 
that certain personality traits and predispositions to develop chronic pain syndromes may 
share common neurological or physiological background should be explored in 
prospective studies.
 A second explanation may be the effect of personality traits on symptom report. 
In healthy individuals, N has consistently been related to enhanced levels of health 
complaints in the absence of illness (Costa & McCrae, 1992; Ellington & Wiebe, 1999). 
O has been associated with increased symptom report during suffering from common 
cold, but not in healthy samples (Feldman et al., 1999). A limitation pertaining to this line 
of research is the absence of studies of the relationship between personality and symptom 
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report in chronic pain groups. Moreover, there may be significant gender effects on this 
relationship. In a study of elderly individuals, high levels of A was related to fewer 
medical problems in women, whereas high levels of C was found in relation to positive 
health perceptions in men only (Jerram & Coleman, 1999).  
 The symptom-amplification effects of NA seem to be mediated by attention; high 
NA is related to a sharpened attention to stimuli emanating from one’s own organism 
(Kolk et al., 2003). It is not known whether other personality traits interact with 
attentional processes in a similar manner. Relatedly, N-associated vigilance to pain may 
predispose the individual to cathastrophizing, e.g., the tendency to interpret internal and 
external stimuli in the worst possible manner (Goubert et al., 2004). Hence, NA and N 
not only seem to direct one’s attention inward, but also to exaggerate the negative impact 
of unpleasant or painful somatic stimuli.   
 A third possibility is that social and psychological consequences of personality 
characteristics may create a risk for chronification of acute pain conditions. Low levels of 
E and O, in particular if combined with high N, may increase the risk of loneliness, 
isolation, and proneness to maladaptive patterns of thought and affective responding. 
Perhaps such experiences may be part of the explanation for the observed maladaptive 
coping strategies in some chronic pain patients (Nitch & Boone, 2004).
The relationship between personality traits and coping strategies seems relevant 
for cooperation with health care workers and adherence to treatment regimes. Although 
we are aware of no study tracking treatment effects (and satisfaction with clinicians) in 
relation to personality traits in chronic illnesses, this topic has long been discussed 
(Mutén, 1991; Smith & Williams, 1992). It is speculated that low O in combination with 
low E may offer particular difficulties in terms of the reduced ability to recognize and 
communicate emotions that may arise from this combination of traits (Phillips & Gatchel, 
2000).
4.2.2 General health complaints in TMD 
The classical TMD profile of elevated levels of psychological distress and extra-cranial 
pain complaints was reproduced. Moreover, we have put this finding on a more secure 
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footing by controlling for the impact of experimental pain sensitivity, N, and self-
presentation bias.
As with the personality-pain association, the present cross-sectional study does 
not permit causal conclusions regarding the pain-general health complaint relationship. 
Emotional distress has been identified both as a precursor to and a consequence of 
chronic pain. The first of these possibilities has received extensive theoretical attention 
for several decades. The comorbidity of psychological distress and pain, in addition to the 
lack of organic abnormalities in many musculoskeletal pain disorders, has generated 
suggestions that chronic pain conditions may be masked psychiatric disorders, with 
patients reporting somatic complaints instead of psychological distress to avoid the social 
stigma of mental instability. The TMD patients in the present study reported elevated 
levels of somatic complaints. Previous studies have found somatization processes to be 
predictive of chronic widespread pain (McBeth et al., 2001) in addition to being 
predictive of poor treatment outcome in established TMD (Rammelsberg et al., 2003; 
Ohrbach & Dworkin, 1998).
An elevated level of somatic symptoms does not necessarily imply that a 
somatization disorder is present. Somatisation processes denote the tendency to 
communicate emotional and social distress through physical symptoms (Bacon et al., 
1994). This tendency is related to, but not equivocal to, the psychiatric diagnosis of 
somatization disorder, which requires a higher number as well as several years of 
symptoms (American Psychiatric Association, 1994). It is not inconceivable that 
somatization may occur secondary to chronic pain. As the pain problem progresses, a 
response may be an increased focus on bodily processes and symptoms (Gatchel & 
Weisberg, 2000), even in individuals with high pre-pain levels of somatization or other 
psychological distress. The ultimate consequence may be a positive feedback-loop where 
chronic pain and negative affect interact in a circular manner. This raises the possibility 
that the relationship between psychological distress and chronic pain, regardless of causal 
direction, may not be linear. In fact, the tendency to overlook possible circular 
relationships is a point of criticism of diathesis-stress models of the relationship between 
psychological distress and somatic health (Gatchel & Weisberg, 2000). In order to avoid 
or reduce the detrimental impact of such a circular relationship, early identification and 
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treatment of psychological distress is pivotal. Indeed, there is recent evidence that this 
type of intervention may prevent the transition to chronic pain in individuals with acute 
TMD (Gatchel et al., 2006). 
Recent findings of common genetic sources of both chronic pain and 
psychological distress challenges the cause-effect way of analysing the pain-distress 
relationship (Diatchenko et al., 2006a). Moreover, the central sensitisation explanation of 
chronic pain regards emotional distress as secondary to the pain problem (Svensson & 
Graven-Nielsen, 2001; Vierck, 2006). The question of which model that best explains the 
pain-distress association, and the question of whether this association is different in 
different subgroups of chronic pain patients, awaits further elucidation.
Compared to the pain-free controls, the TMD patients of the present study 
reported significantly higher levels of headache and pain in the neck, back, and legs. 
There were, however, considerable inter-individual variations in the TMD group as 
evidenced by the large standard deviations of the analyses. Possibly, some groups of 
TMD patients are more troubled by generalised pain than the others.
An issue arising at this point is the relationship between TMD and FMS on the 
one hand and TMD and chronic tension-type headache (CTTH) on the other. One study 
found that general musculoskeletal pain predates orofacial pain and concluded that TMD 
may simply be a characteristic of late-stage FMS (Hedenberg-Magnusson et al., 1999). 
Despite similarities, there seems to be important differences between these illnesses, as 
Dao et al. (1997) have found that a sizable minority (21%) of TMD patients had orofacial 
pain for up to 15 years without general body pain. Moreover, FMS seems to be 
characterized by more severe pain and higher levels of psychological distress (Dao et al., 
1997; Plesh et al., 1996). In addition, the prevalence of TMD does not seem to increase 
with age the way FMS does (Dao et al., 1997; Plesh et al., 1996). Possibly, TMD and 
FMS occupy different ends of a continuous spectrum of chronic musculoskeletal pain 
resulting from similar, as of yet unknown, etiological factors.   
However, the possibility that some of our patients would have been diagnosed 
with FMS can not be ruled out. The presence of (>11of 18) tender points as detected by 
palpation by the clinician is required for the diagnosis of FMS (Wolfe et al., 1990), and 
our patients were not examined with respect to the FMS diagnostic criteria. In addition to 
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the presence of tender points, however, other FMS diagnosis criteria are widespread 
chronic pain, psychological distress, sleep problems, and fatigue. We found significant 
group differences in self-reported headache, neck pain, and pain in the upper and lower 
back, chest, and legs, as well as psychological distress. These symptoms may be 
indicative of FMS being present in at least some of our patients. 
 Likewise, the relationship of TMD to CTTH is difficult to entangle. Based on the 
significant group differences in self-reported headache, at least some of our patients may 
have been candidates for a CTTH diagnosis. CTTH (i.e., idiopathic headache more than 
15 days pr. month for more than 3 months, International Headache Society; 2004) may be 
a consequence of facial pain, or orofacial pain may result from tension type headache due 
to central sensitization (Bendtsen, 2000). Moreover, both facial pain and headache may 
be symptoms of a common musculoskeletal pain disorder, e.g., FMS (Wolfe et al., 1990). 
Despite the common finding of comorbidity of TMD and headache (e.g., Ciancaglini & 
Radaelli, 2001), and the increasing frequency of CTTH in the Western population 
(Bendtsen & Jensen, 2006), there is surprisingly little research into this relationship.
 In the absence of clear biological markers for each diagnostic category, the only 
way to disentangle the relationship between TMD, FMS, and CTTH – as well as other 
conditions assumed to be functional somatic syndromes – is to conduct a thorough 
investigative process where individuals presenting with these symptoms are subject to 
diagnostization according to the criteria of each of these conditions. Normally, one seeks 
out specialist care based on the most dominant symptoms and complaints, e.g., someone 
suffering from persistent, strong orofacial pain may be referred to a dental clinic even if 
persistent pain, albeit of lower intensity, is present in other parts of the body. The 
classification of such an individual as a TMD sufferer may be somewhat arbitrary; 
possibly, an FMS diagnosis could also be correct given a sufficient number of extra-
cranial tender points. To date, no such extensive study of the functional somatic 
syndromes has been undertaken. 
4.2.3 Experimental pain sensitivity in TMD 
Two of the present findings contrast with most previous research in experimental pain 
sensitivity in TMD. First, the TMD group exhibited significantly lower electrocutaneous 
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pain sensitivity and only a non-significant trend of higher pressure pain sensitivity at 
baseline. Second, the significant correlations between experimental pain sensitivity and 
CV responding that has been reported in pain-free men, in this study occurred in the 
female TMD group.  
4.2.3.1 Pain sensitivity
The post-contraction reduction in pain thresholds at all anatomical sites tested in the 
TMD group is suggestive of an enhanced generalized sensitivity due to local muscular 
load. A similar finding has been reported in FMS (Staud et al., 2005), and taken as 
evidence that chronic pain conditions are explainable in terms of central sensitization. A 
further support of this notion comes from the above finding that the TMD group reported 
elevated levels of general musculoskeletal pain relative to the controls, but that there 
were no group differences in other somatic complaints. This suggests that TMD patients 
are not global complainers in search of medical attention, despite the uncertain organic 
basis for their symptoms, but that a central sensitization process is in operation. 
 Tonic nociceptive input to the CNS may generate central sensitization (Vierck, 
2006), and muscle contractions could be a source of such input (Staud et al., 2005). 
Several intramuscular processes may be involved in the sensitization of muscle afferents, 
e.g., release of growth hormones, reduced muscle blood flow, and increases in 
metabolites (Vierck, 2006). On the other hand, aerobic exercise and strength training 
have been efficient in reducing clinical pain in FMS patients (e.g., Richards & Scott, 
2002). The point at which physical exercise becomes harmful in chronic musculoskeletal 
pain patients is not established. However, the muscular load of the present study as well 
as of the study of Staud et al. (2005) was static and strenuous. The type of exercise 
recommended in rehabilitation studies are typically non-static, of low to moderate 
intensity, and is based upon activities that most people naturally perform and find 
enjoyable, i.e., stretching, leisurely walking, dancing, swimming or stretching in warm 
water (Zijlstra et al., 2005; Richards & Scott, 2002). These activities may not 
compromise muscle physiology the same way that isometric contractions do, but benefit 
the organism by improving CV function and increasing muscular blood flow.     
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The lack of significantly higher pain sensitivity in the TMD group at baseline was 
surprising. Several explanations may be offered. First, there may be large variations in 
pain sensitivity within chronic pain populations, as observed by Giesecke et al (2003) in 
FMS patients. In spite of the general tendency for chronic pain groups to demonstrate 
higher pain sensitivity than pain-free controls, several studies exist that have not found 
this association. This point may be particularly relevant in a relatively small sample. 
Moreover, our study is limited by the fact that we did not assess sensory or affective 
experiences of the pain stimulation in Papers I-III. Such a procedure would have provided 
more information on the participants’ experience of pain and may have shed light on the 
unexpected baseline findings.
In a study of chronic low back pain patients and healthy controls, Peters & 
Schmidt (1992) found a significantly lower electrocutaneous and pressure pain sensitivity 
in the chronic pain group. Boureau et al. (1991) found that their sample of mixed chronic 
pain conditions reported the same electrocutaneous pain sensitivity as the healthy control 
group. The authors suggest two possible explanations for these results. First, the long-
term adaptation to pain that these patients experience may reduce their tendency to label 
experimental pain stimulation as painful (Peters & Schmidt, 1992; Boureau et al., 1991). 
Second, the presence of chronic pain could generate a neurophysiological inhibition of 
experimental pain perception through a diffuse noxious inhibitory control (DNIC) 
mechanism (Peters & Schmidt, 1992; Boureau et al., 1991). However, more recent 
studies have found that DNIC phenomena generally modulate pain perception in healthy 
males, and not in healthy females or FMS patients (Staud et al., 2003; Lautenbacher & 
Rollman, 1997) or facial pain (Sigurdsson & Maixner, 1994). On the other hand, a 
critique of DNIC studies has been offered by Vierck (2006), who argues that the findings 
of Staud et al. (2003) and Lautenbacher & Rollman (1997) are confounded by enhanced 
attentional focus on the clinical pain due to acute pain stimulation.  It is not possible to 
rule out DNIC phenomena in explaining the present data.  
A second explanation for our baseline findings may be that different methods of 
pain stimulation are used. We employed electrocutaneous and pressure pain, in contrast 
to ischemic and heat pain used in the studies by Bragdon et al. (2002) and Maixner et al. 
(1997). In a previous study, no group differences have been reported regarding 
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electrocutaneous pain sensitivity in FMS patients and healthy controls (Lautenbacher & 
Rollman, 1997). In another study, electrocutaneous sensitivity was significantly lower in 
TMD patients compared to pain-free controls (Hagberg et al., 1990). Moreover, in the 
same study, the lowest acute pain thresholds were found in TMD patients with the 
highest clinical pain ratings (Hagberg, 1990). In our study, the clinical pain ratings 
obtained at various intervals throughout the experiment were relatively low (see Paper 
II). In addition, none of our patients were disabled and only 9% on sick leave. These 
findings suggest that most of those who participated in our time-consuming and 
presumably stressful study belong to the sub-group of patients with relatively low clinical 
pain and functional impact. However, a limitation of the present study is that the TMD 
patients’ overall functional status and impact on symptoms on the performance of 
activities of daily life was not assessed. 
However, the lack of significant group difference of pressure pain sensitivity at 
the masseter muscle was surprising, as measurements were performed at a site that is 
frequently painful to palpation in TMD (Dworkin & LeResche, 1992). Indeed, Sarlani & 
Greenspan (2003) note that TMD patients, relative to healthy controls, tend to be more 
sensitive to pressure pain, but not necessarily to electrically evoked pain. This notion is 
supported by a study by Svensson et al. (2001), demonstrating increased pressure pain 
sensitivity, but not heat pain sensitivity, in the masseter muscle of TMD patients 
compared to pain-free controls. There was, however, a non-significant trend of lower 
pressure pain sensitivity in our TMD patients.
4.2.3.2 The CVR - pain sensitivity relationship
The present results contrast with previous reports, e.g., by Bragdon et al. (2002) and 
Maixner et al. (1997). Surprisingly, all significant correlations between MAP and pain 
sensitivity were seen in the TMD group. This was not due to the influence of state affect, 
as there were no significant correlations between the STPI-State scales and MAP in the 
TMD group. One possible explanation for the present finding may be that we employed 
electrocutaneous and pressure pain stimulation, whereas Bragdon et al. (2002) and 
Maixner et al. (1997) assessed the responses to ischemic and thermal pain stimulation, 
suggesting that there may be a differential relationship between cardiovascular responses 
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and pain sensitivity induced by different stimulation modalities, triggering different 
classes of nociceptors.
The findings of a clear pattern of significant correlations between CVR and pain 
sensitivity, are supportive of a model where CVR and hypoalgesia are not causally 
related, but occur simultaneously due to central nervous changes that have yet to be 
elucidated (France, 1999). It is not known why this correlational model was supported 
only in the TMD group in this study. The conflicting results of studies of the relationship 
between CVR and pain sensitivity, which may at least partly be explained by 
methodological differences (France, 1999) do not offer the empirical background 
required for a discussion of causative central nervous processes. Our findings should be 
replicated before it may be concluded that the superficial type of pain evoked by 
electrocutaneous stimulation is indeed differently related to CVR in TMD patients 
compared to healthy controls, or that these results are indicative of an underlying 
psychophysiological dysfunction in chronic pain patients.
 Paper IV describes parts of a study intended to investigate in more detail some of 
the findings of Paper II. We employed continuous blood pressure recordings, and the test-
retest reliablilty of our pain stimulation trials was high. This permits a large degree of 
confidence in our results. We found a non-significant trend of associations between 
'MAP and 'HR and pain sensitivity after the arousing job interview, so until our results 
are replicated with a larger sample, it is not possible to dismiss the CVR-pain relationship 
in normotensive, pain-free women altogether. Although the CVR-pain relationship has 
been assumed to occur mainly in men (Bragdon et al., 2002; Maixner et al., 1997), Bruehl 
et al. (2002) reported that increases in systolic blood pressure was related to decreased 
ratings of finger pressure pain intensity in both genders. Bearing in mind the sparse 
literature on CVR and pressure pain, these results suggest that pressure pain is related to 
CVR in a different manner than are ischemic and heat pain, perhaps related to activities 
of different regions of the PAG during deep and superficial pain stimulation (Bandler & 
Shipley, 1994).
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4.2.4 The CVR – emotional dampening relationship 
Our results (Paper IV) provide no strong support for the hypothesis that CV responding is 
correlated both with attenuated pressure pain sensitivity and general emotional 
dampening (Pury et al., 2004). Several methodological characteristics strengthen these 
findings: We controlled for menstrual cycle events, weekend-related changes in 
physiology, and the CV changes during pain stimulation. In addition, we analysed 
cardiovascular and pain stimulation data obtained at three points during the experiment: 
before, during, and after the arousing intervention.
 However, our sample (N = 39) was smaller than the one of Pury et al. (2004) (N = 
57). Some of our non-significant negative correlations between CVR and affective 
responses to pain stimulation and to the job-interview may have turned out significant 
given a larger sample. Hence, it may be wrong to dismiss the CVR-emotional dampening 
hypothesis altogether based on the current data. On the other hand, there were significant 
positive associations between CVR and general state affect during the experiment, 
indicating a classical stress-activation response where increases in negative affect occur 
in parallel with increases in CVR. It would seem prudent to consider the debate of the 
emotional dampening hypothesis as still undecided.
4.2.5 Psychophysiological responding in TMD 
The TMD patients exhibited consistently lower levels of masseter EMG during relaxation 
periods and cognitive tasks. This finding contradicts previous reports of muscular 
hyperactivity in chronic musculoskeletal pain (Flor et al., 1991; 1992), but agrees with 
the pain-adaptation model (Lund et al., 1991), suggesting that reduced levels of EMG 
occur in response to pain in order to avoid further pain or harm. However, the 
generalizability of our findings is limited by the fact that we did not control for 
consumption of analgesics or muscle relaxants in the TMD group on the day of the 
experiment.  
As there were higher levels of negative affect in the TMD group during the 
experiment, our results present a challenge to the diathesis-stress model of Flor et al. 
(1991; 1992). An issue arising at this point is the sensitivity of our job interview in 
generating distress. Was this task sufficiently emotionally challenging to generate 
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muscular hyper-reactivity in the TMD group if the diathesis-stress model is correct? This 
is most likely, given that the MAP and HR levels of our participants were significantly 
elevated during this task. In the studies of Flor et al. (1991; 1992), the emotionally 
stressful task was personally distressing imagery, whereas our participants actively 
performed the arousing task through verbalization. Moreover, the increased levels of 
MAP and HR during the job interview indicate that this task generated significant 
arousal.
The modest number of significant group differences in physiological responding 
coupled with significant group differences in self-reported affect is in line with other 
studies. In matched samples roughly the same sizes as ours, Curran et al. (1996) observed 
higher levels of anger, anxiety, and sadness in TMD patients relative to controls during 
stress (mental arithmetic), but no differences in finger pressure pain or EMG levels. 
Similarly, in a study of 34 TMD patient and 18 controls, Carlson et al. (1993) 
demonstrated that the TMD group was characterised by higher levels of anxiety and 
higher systolic blood pressure and HR during stress (mental arithmetic), while subjective 
reports of muscle tension was not paralleled by EMG changes.  
Such findings suggest that the behavioural-physiological adaptation and 
cognitive-affective response systems are two separate parts of the stress-response systems 
and are not necessarily highly correlated. However, it may be argued that absence of 
evidence is not evidence of absence. The fact that several investigators have failed to 
detect group differences in physiological responding does not necessarily mean that 
differences do not exist. Instead, the detection methods currently available may not be 
sufficiently sensitive to demonstrate subtle changes in skin and muscle physiology.  
These results, in combination with the significant group differences in subjective 
health complaints (Paper I), add to several reports of a discrepancy between a marked 
presence of suffering and perceived ill-health and few physiological signs of disease in 
TMD patients as well as in other chronic musculoskeletal pain disorders such as FMS and 
CTTH (Aaron et al., 2000; Barsky & Borus, 1999). The identification of causal factors 
behind this discrepancy, which should be carried out in parallel with a continued search 
for biological markers of chronic musculoskeletal disorders, should be assigned priority 
in future research efforts.  
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5 Conclusions and practical implications
The TMD patients exhibited a lower level of the personality traits E and O. Higher levels 
of psychological distress and musculoskeletal pain in the TMD group relative to the 
control group were observed. Hence, the typical TMD profile of affective distress and 
extra-craniofacial pain was reproduced. Importantly, these differences in general health 
complaints were maintained after having statistically controlled for N, reporting bias, 
and acute pain sensitivity. 
It is recommended that TMD patients undergo a personality screening in order to 
identify traits that are relevant for adjustment to chronic pain and cooperation with health 
care workers.  Moreover, the possibility that personality traits affect symptom report 
differently in chronic pain groups and healthy samples needs to be elucidated.
Regardless of causal direction between affective tone and chronic pain, the 
present data fit well with the consistent findings of TMD patients being characterized by 
psychological distress as well as chronic pain, and that psychological function should be 
targeted during treatment in parallel with the pain problem.  
The findings of increased levels of self-reported general musculoskeletal pain in 
TMD patients, but no group differences in gastrointestinal, allergy, or upper airway 
infection symptoms, indicate that TMD patients are not global complainers. Possibly, a 
central sensitization process has taken place, although it must be acknowledged that in 
our study, there were few group differences in experimental pain sensitivity. This is 
important, as the lack of identifiable organic causes for their pain sometimes results in 
TMD patients being told that their pain “is all in the head”. The rate of development of 
central sensitization processes as well as risk factors should be studied in sub-chronic 
samples or ideally prospectively with individuals healthy at baseline.
Relative to the control group, the TMD group exhibited a significantly higher 
electrocutaneous pain threshold and non-significantly lower pressure pain thresholds at 
baseline. After isometric contraction of the jaw, the TMD group exhibited increased 
general pain sensitivity, while this did not occur in the control group. This finding may be 
interpreted in terms of a central sensitization process.  
The arousing job interview did not significantly affect the subsequent pain 
perception in any group. Significant positive correlations between MAP and pain 
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thresholds and tolerance were seen in the TMD group. These data indicate that the CVR – 
pain sensitivity relationship may be dependent on method of pain stimulation. Moreover, 
to the best of the author’s knowledge, this study is the first to demonstrate that also 
women with TMD may experience the correlational relationship between CV responding 
and pain previously thought to occur mainly in pain-free men. The study of pain 
attenuation in the face of increased CV responding in chronic pain groups is, however, 
still in its infancy.  
The cognitive tasks elicited significant MAP, HR, and SBF responses, and, 
overall, these were similar in the two groups, providing no support for the notion that 
TMD is related to a general psychophysiological dysfunction. There were significantly 
lower levels in masseter EMG in the TMD group during relaxation and the cognitive 
tasks, suggestive of a pain adaptation process in the region affected by clinical pain.
  Relative to the controls, the TMD patients were more distressed during the 
experiment, as evidenced by their report of higher levels of state anxiety and depression 
as well as a more negative experience of the job-interview. These findings, in addition to 
the marked group differences in general health complaints, point in the direction of 
subjective reports of orofacial symptoms and general health being more reliable 
indicators of a TMD diagnosis than would assessments of general psychophysiological 
responding during stressful tasks. 
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